Glivec granted 5 years of exclusive marketing rights in India News item 10 February 2013 Pages: 22 - 22
Gonadotropin releasing hormone antagonist, Plenaxis, receives US FDA approval Media release 10 February 2013 Pages: 22 - 22
Quetiapine valuable agent for treating levodopa-induced dyskinesia Clinical study 10 February 2013 Pages: 22 - 22